The De Simone Formulation in CDS22-formula is the only probiotic formulation recommended and recognized by namein the guidelines of the American Gastroenterology Association (AGA) for the management of gastrointestinal disorders (Olleik et al., Gastroenterology, Vol. 164, No. 6, 2023). (Olleik et al., Gastroenterology, Vol. 164, No. 6, 2023).
The European Crohn’s and Colitis Organization (ECCO) has also included the De Simone Formulation in its guidelines for managing intestinal disorders (ECCO, ECCO News, 2023).
CDS22-formula is highly effective in the dietary management of various gastrointestinal conditions.The extensive scientific evidence, comprising over 200 peer-reviewed articles and more than 80 controlled clinical studies, ensures that the benefits observed in clinical trials are replicable in everyday use
Not all probiotics are the same. The overall biological action of a probiotic is not simply the sum of its individual components’ actions but the result of a complex network of relationships between the microorganisms it contains and the human host. Unlike many other products on the market, the clinical results obtained from CDS22-formula speak louder than any technical description.
CDS22-formula combines 8 bacterial strains selected for their biochemical and enzymatic profiles and specifically calibrated in precise proportions to synergistically act on the physiology of the human gastrointestinal tract.
È fondamentale evidenziare che la produzione della De Simone Formulation si colloca nel campo della biologia e non della chimica, poiché i batteri che costituiscono la base del prodotto sono organismi viventi. La loro coltivazione richiede conoscenze scientifiche avanzate e un know-how specifico, tuttora protetto da segreto industriale.
The unique and advanced know-how developed by Prof. Claudio De Simone, which includes specific industrial secrets, contributes to the uniqueness and efficacy of CDS22-formula, making it extremely difficult for others to replicate or produce an identical or functionally equivalent product.
Supported by solid scientific evidence, CDS22-formula is highly effective in the dietary management of dysbiosis and other gastrointestinal conditions, offering proven and replicable clinical results.
Cookie policy e Privacy policy - Realizzato da KLODBERSA
© 2024 CDS22-Formula | Tutti i diritti sono riservati